Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 22249-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- RBM15B antibody
- Antibody type
- Polyclonal
- Description
- RBM15B antibody (Cat. #22249-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression.
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128-3p/MAPK1 axis.
The predictive significance of a 5-m6A RNA methylation regulator signature in colorectal cancer.
SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants.
A lncRNA from the FTO locus acts as a suppressor of the m(6)A writer complex and p53 tumor suppression signaling.
Human lncRNA SUGCT-AS1 Regulates the Proinflammatory Response of Macrophage.
m6A Regulatory Gene-Mediated Methylation Modification in Glioma Survival Prediction.
The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance.
mTORC1 stimulates cell growth through SAM synthesis and m(6)A mRNA-dependent control of protein synthesis.
METTL3 regulates heterochromatin in mouse embryonic stem cells.
Altered Expression of the m6A Methyltransferase METTL3 in Alzheimer's Disease.
Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Wang K, Bhattacharya A, Haratake N, Daimon T, Nakashoji A, Ozawa H, Peng B, Li W, Kufe D
Cell death & disease 2024 May 13;15(5):330
Cell death & disease 2024 May 13;15(5):330
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128-3p/MAPK1 axis.
Yi J, Ma X, Ying Y, Liu Z, Tang Y, Shu X, Sun J, Wu Y, Lu D, Wang X, Luo J, Liu B, Zheng X, Lin Y, Li J, Xie L
Cancer letters 2024 Mar 31;585:216613
Cancer letters 2024 Mar 31;585:216613
The predictive significance of a 5-m6A RNA methylation regulator signature in colorectal cancer.
Zhang D, Wu G, Yang L, Wu Q, Yuan L
Heliyon 2023 Oct;9(10):e20172
Heliyon 2023 Oct;9(10):e20172
SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants.
Lin R, Kos A, Lopez JP, Dine J, Fiori LM, Yang J, Ben-Efraim Y, Aouabed Z, Ibrahim P, Mitsuhashi H, Wong TP, Ibrahim EC, Belzung C, Blier P, Farzan F, Frey BN, Lam RW, Milev R, Muller DJ, Parikh SV, Soares C, Uher R, Nagy C, Mechawar N, Foster JA, Kennedy SH, Chen A, Turecki G
eLife 2023 Jul 11;12
eLife 2023 Jul 11;12
A lncRNA from the FTO locus acts as a suppressor of the m(6)A writer complex and p53 tumor suppression signaling.
Zhang J, Wei J, Sun R, Sheng H, Yin K, Pan Y, Jimenez R, Chen S, Cui XL, Zou Z, Yue Z, Emch MJ, Hawse JR, Wang L, He HH, Xia S, Han B, He C, Huang H
Molecular cell 2023 Aug 3;83(15):2692-2708.e7
Molecular cell 2023 Aug 3;83(15):2692-2708.e7
Human lncRNA SUGCT-AS1 Regulates the Proinflammatory Response of Macrophage.
Lim YH, Yoon G, Ryu Y, Jeong D, Song J, Kim YS, Ahn Y, Kook H, Kim YK
International journal of molecular sciences 2023 Aug 28;24(17)
International journal of molecular sciences 2023 Aug 28;24(17)
m6A Regulatory Gene-Mediated Methylation Modification in Glioma Survival Prediction.
Zhang G, Zheng P, Lv Y, Shi Z, Shi F
Frontiers in genetics 2022;13:873764
Frontiers in genetics 2022;13:873764
The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance.
Li Z, Zheng C, Huang L, Yin X, Wang Z, Liu C, Li B
Annals of translational medicine 2022 Dec;10(24):1347
Annals of translational medicine 2022 Dec;10(24):1347
mTORC1 stimulates cell growth through SAM synthesis and m(6)A mRNA-dependent control of protein synthesis.
Villa E, Sahu U, O'Hara BP, Ali ES, Helmin KA, Asara JM, Gao P, Singer BD, Ben-Sahra I
Molecular cell 2021 May 20;81(10):2076-2093.e9
Molecular cell 2021 May 20;81(10):2076-2093.e9
METTL3 regulates heterochromatin in mouse embryonic stem cells.
Xu W, Li J, He C, Wen J, Ma H, Rong B, Diao J, Wang L, Wang J, Wu F, Tan L, Shi YG, Shi Y, Shen H
Nature 2021 Mar;591(7849):317-321
Nature 2021 Mar;591(7849):317-321
Altered Expression of the m6A Methyltransferase METTL3 in Alzheimer's Disease.
Huang H, Camats-Perna J, Medeiros R, Anggono V, Widagdo J
eNeuro 2020 Sep Oct;7(5)
eNeuro 2020 Sep Oct;7(5)
Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y, Liu X, Liu L, Li J, Hu Q, Sun R
Medical science monitor : international medical journal of experimental and clinical research 2020 Feb 22;26:e919644
Medical science monitor : international medical journal of experimental and clinical research 2020 Feb 22;26:e919644
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The RBM15B antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human RBM15B. This antibody recognizes human, mouse, rat antigen. The RBM15B antibody has been validated for the following applications: ELISA, WB analysis.
